Evaluation	B:C0220825
of	O
Local	O
CYP17A1	O
and	O
CYP19A1	O
Expression	O
Levels	O
as	O
Prognostic	O
Factors	I:C1514474
in	O
Postmenopausal	O
Invasive	O
Ductal	I:C1134719
Breast	I:C1134719
Cancer	I:C1134719
Cases	O

Evaluation	O
of	O
Local	B:C0205276
CYP17A1	O
and	O
CYP19A1	O
Expression	O
Levels	O
as	O
Prognostic	O
Factors	I:C1514474
in	O
Postmenopausal	O
Invasive	O
Ductal	I:C1134719
Breast	I:C1134719
Cancer	I:C1134719
Cases	O

Evaluation	O
of	O
Local	O
CYP17A1	B:C1413858
and	O
CYP19A1	O
Expression	O
Levels	O
as	O
Prognostic	O
Factors	I:C1514474
in	O
Postmenopausal	O
Invasive	O
Ductal	I:C1134719
Breast	I:C1134719
Cancer	I:C1134719
Cases	O

Evaluation	O
of	O
Local	O
CYP17A1	O
and	O
CYP19A1	B:C1366496
Expression	O
Levels	O
as	O
Prognostic	O
Factors	I:C1514474
in	O
Postmenopausal	O
Invasive	O
Ductal	I:C1134719
Breast	I:C1134719
Cancer	I:C1134719
Cases	O

Evaluation	O
of	O
Local	O
CYP17A1	O
and	O
CYP19A1	O
Expression	O
Levels	O
as	O
Prognostic	B:C1514474
Factors	I:C1514474
in	O
Postmenopausal	O
Invasive	O
Ductal	I:C1134719
Breast	I:C1134719
Cancer	I:C1134719
Cases	O

Evaluation	O
of	O
Local	O
CYP17A1	O
and	O
CYP19A1	O
Expression	O
Levels	O
as	O
Prognostic	O
Factors	I:C1514474
in	O
Postmenopausal	B:C0232970
Invasive	O
Ductal	I:C1134719
Breast	I:C1134719
Cancer	I:C1134719
Cases	O

Evaluation	O
of	O
Local	O
CYP17A1	O
and	O
CYP19A1	O
Expression	O
Levels	O
as	O
Prognostic	O
Factors	I:C1514474
in	O
Postmenopausal	O
Invasive	B:C1134719
Ductal	I:C1134719
Breast	I:C1134719
Cancer	I:C1134719
Cases	O

There	O
is	O
growing	O
attention	O
focused	O
on	O
local	B:C0205276
estrogen	O
production	I:C1157310
in	O
the	O
breast	O
tissue	I:C1521747
and	O
its	O
possible	O
role	O
in	O
breast	O
cancer	I:C0006142
initiation	O
and	O
progression	O
.	O

There	O
is	O
growing	O
attention	O
focused	O
on	O
local	O
estrogen	B:C1157310
production	I:C1157310
in	O
the	O
breast	O
tissue	I:C1521747
and	O
its	O
possible	O
role	O
in	O
breast	O
cancer	I:C0006142
initiation	O
and	O
progression	O
.	O

There	O
is	O
growing	O
attention	O
focused	O
on	O
local	O
estrogen	O
production	I:C1157310
in	O
the	O
breast	B:C1521747
tissue	I:C1521747
and	O
its	O
possible	O
role	O
in	O
breast	O
cancer	I:C0006142
initiation	O
and	O
progression	O
.	O

There	O
is	O
growing	O
attention	O
focused	O
on	O
local	O
estrogen	O
production	I:C1157310
in	O
the	O
breast	O
tissue	I:C1521747
and	O
its	O
possible	O
role	O
in	O
breast	B:C0006142
cancer	I:C0006142
initiation	O
and	O
progression	O
.	O

There	O
is	O
growing	O
attention	O
focused	O
on	O
local	O
estrogen	O
production	I:C1157310
in	O
the	O
breast	O
tissue	I:C1521747
and	O
its	O
possible	O
role	O
in	O
breast	O
cancer	I:C0006142
initiation	O
and	O
progression	B:C1947901
.	O

Understanding	O
the	O
underlying	O
mechanisms	O
for	O
estrogen	B:C1157310
synthesis	I:C1157310
and	O
the	O
microenvironment	O
consisting	O
of	O
tumor	O
and	O
its	O
surrounding	O
adipose	O
tissue	I:C0001527
might	O
open	O
new	O
avenues	O
in	O
breast	O
cancer	I:C0281189
prevention	I:C0281189
,	O
prognosis	O
and	O
treatment	O
.	O

Understanding	O
the	O
underlying	O
mechanisms	O
for	O
estrogen	O
synthesis	I:C1157310
and	O
the	O
microenvironment	O
consisting	O
of	O
tumor	B:C0027651
and	O
its	O
surrounding	O
adipose	O
tissue	I:C0001527
might	O
open	O
new	O
avenues	O
in	O
breast	O
cancer	I:C0281189
prevention	I:C0281189
,	O
prognosis	O
and	O
treatment	O
.	O

Understanding	O
the	O
underlying	O
mechanisms	O
for	O
estrogen	O
synthesis	I:C1157310
and	O
the	O
microenvironment	O
consisting	O
of	O
tumor	O
and	O
its	O
surrounding	O
adipose	B:C0001527
tissue	I:C0001527
might	O
open	O
new	O
avenues	O
in	O
breast	O
cancer	I:C0281189
prevention	I:C0281189
,	O
prognosis	O
and	O
treatment	O
.	O

Understanding	O
the	O
underlying	O
mechanisms	O
for	O
estrogen	O
synthesis	I:C1157310
and	O
the	O
microenvironment	O
consisting	O
of	O
tumor	O
and	O
its	O
surrounding	O
adipose	O
tissue	I:C0001527
might	O
open	O
new	O
avenues	O
in	O
breast	B:C0281189
cancer	I:C0281189
prevention	I:C0281189
,	O
prognosis	O
and	O
treatment	O
.	O

Understanding	O
the	O
underlying	O
mechanisms	O
for	O
estrogen	O
synthesis	I:C1157310
and	O
the	O
microenvironment	O
consisting	O
of	O
tumor	O
and	O
its	O
surrounding	O
adipose	O
tissue	I:C0001527
might	O
open	O
new	O
avenues	O
in	O
breast	O
cancer	I:C0281189
prevention	I:C0281189
,	O
prognosis	B:C1516221
and	O
treatment	O
.	O

Understanding	O
the	O
underlying	O
mechanisms	O
for	O
estrogen	O
synthesis	I:C1157310
and	O
the	O
microenvironment	O
consisting	O
of	O
tumor	O
and	O
its	O
surrounding	O
adipose	O
tissue	I:C0001527
might	O
open	O
new	O
avenues	O
in	O
breast	O
cancer	I:C0281189
prevention	I:C0281189
,	O
prognosis	O
and	O
treatment	B:C0087111
.	O

In	O
order	O
to	O
obtain	O
insight	O
,	O
we	O
compared	O
peritumoral	B:C3897941
and	O
tumor	O
tissue	I:C0475358
expressions	O
of	O
CYP17A1	O
and	O
CYP19A1	O
genes	O
,	O
which	O
play	O
an	O
important	O
role	O
in	O
estrogen	O
biosynthesis	I:C1157310
.	O

In	O
order	O
to	O
obtain	O
insight	O
,	O
we	O
compared	O
peritumoral	O
and	O
tumor	B:C0475358
tissue	I:C0475358
expressions	O
of	O
CYP17A1	O
and	O
CYP19A1	O
genes	O
,	O
which	O
play	O
an	O
important	O
role	O
in	O
estrogen	O
biosynthesis	I:C1157310
.	O

In	O
order	O
to	O
obtain	O
insight	O
,	O
we	O
compared	O
peritumoral	O
and	O
tumor	O
tissue	I:C0475358
expressions	B:C0017262
of	O
CYP17A1	O
and	O
CYP19A1	O
genes	O
,	O
which	O
play	O
an	O
important	O
role	O
in	O
estrogen	O
biosynthesis	I:C1157310
.	O

In	O
order	O
to	O
obtain	O
insight	O
,	O
we	O
compared	O
peritumoral	O
and	O
tumor	O
tissue	I:C0475358
expressions	O
of	O
CYP17A1	B:C1413858
and	O
CYP19A1	O
genes	O
,	O
which	O
play	O
an	O
important	O
role	O
in	O
estrogen	O
biosynthesis	I:C1157310
.	O

In	O
order	O
to	O
obtain	O
insight	O
,	O
we	O
compared	O
peritumoral	O
and	O
tumor	O
tissue	I:C0475358
expressions	O
of	O
CYP17A1	O
and	O
CYP19A1	B:C1366496
genes	O
,	O
which	O
play	O
an	O
important	O
role	O
in	O
estrogen	O
biosynthesis	I:C1157310
.	O

In	O
order	O
to	O
obtain	O
insight	O
,	O
we	O
compared	O
peritumoral	O
and	O
tumor	O
tissue	I:C0475358
expressions	O
of	O
CYP17A1	O
and	O
CYP19A1	O
genes	O
,	O
which	O
play	O
an	O
important	O
role	O
in	O
estrogen	B:C1157310
biosynthesis	I:C1157310
.	O

The	O
paired	O
tissue	B:C0475358
samples	I:C0475358
of	O
20	O
postmenopausal	O
ER	O
(+	I:C0279754
)	I:C0279754
/	O
PR	O
(+	I:C0279759
)	I:C0279759
patients	O
diagnosed	O
with	O
invasive	O
ductal	I:C1134719
breast	I:C1134719
cancer	I:C1134719
were	O
studied	O
.	O

The	O
paired	O
tissue	O
samples	I:C0475358
of	O
20	O
postmenopausal	B:C0232970
ER	O
(+	I:C0279754
)	I:C0279754
/	O
PR	O
(+	I:C0279759
)	I:C0279759
patients	O
diagnosed	O
with	O
invasive	O
ductal	I:C1134719
breast	I:C1134719
cancer	I:C1134719
were	O
studied	O
.	O

The	O
paired	O
tissue	O
samples	I:C0475358
of	O
20	O
postmenopausal	O
ER	B:C0279754
(+	I:C0279754
)	I:C0279754
/	O
PR	O
(+	I:C0279759
)	I:C0279759
patients	O
diagnosed	O
with	O
invasive	O
ductal	I:C1134719
breast	I:C1134719
cancer	I:C1134719
were	O
studied	O
.	O

The	O
paired	O
tissue	O
samples	I:C0475358
of	O
20	O
postmenopausal	O
ER	O
(+	I:C0279754
)	I:C0279754
/	O
PR	B:C0279759
(+	I:C0279759
)	I:C0279759
patients	O
diagnosed	O
with	O
invasive	O
ductal	I:C1134719
breast	I:C1134719
cancer	I:C1134719
were	O
studied	O
.	O

The	O
paired	O
tissue	O
samples	I:C0475358
of	O
20	O
postmenopausal	O
ER	O
(+	I:C0279754
)	I:C0279754
/	O
PR	O
(+	I:C0279759
)	I:C0279759
patients	O
diagnosed	B:C0011900
with	O
invasive	O
ductal	I:C1134719
breast	I:C1134719
cancer	I:C1134719
were	O
studied	O
.	O

The	O
paired	O
tissue	O
samples	I:C0475358
of	O
20	O
postmenopausal	O
ER	O
(+	I:C0279754
)	I:C0279754
/	O
PR	O
(+	I:C0279759
)	I:C0279759
patients	O
diagnosed	O
with	O
invasive	B:C1134719
ductal	I:C1134719
breast	I:C1134719
cancer	I:C1134719
were	O
studied	O
.	O

In	O
addition	O
,	O
12	O
breast	B:C0444070
tissue	I:C0444070
samples	I:C0444070
obtained	O
from	O
premenopausal	O
women	O
without	O
a	O
history	O
of	O
breast	O
cancer	I:C0006142
were	O
also	O
investigated	O
as	O
representative	O
of	O
normal	O
conditions	I:C0231162
.	O

In	O
addition	O
,	O
12	O
breast	O
tissue	I:C0444070
samples	I:C0444070
obtained	O
from	O
premenopausal	B:C0279752
women	O
without	O
a	O
history	O
of	O
breast	O
cancer	I:C0006142
were	O
also	O
investigated	O
as	O
representative	O
of	O
normal	O
conditions	I:C0231162
.	O

In	O
addition	O
,	O
12	O
breast	O
tissue	I:C0444070
samples	I:C0444070
obtained	O
from	O
premenopausal	O
women	B:C0043210
without	O
a	O
history	O
of	O
breast	O
cancer	I:C0006142
were	O
also	O
investigated	O
as	O
representative	O
of	O
normal	O
conditions	I:C0231162
.	O

In	O
addition	O
,	O
12	O
breast	O
tissue	I:C0444070
samples	I:C0444070
obtained	O
from	O
premenopausal	O
women	O
without	O
a	O
history	O
of	O
breast	B:C0006142
cancer	I:C0006142
were	O
also	O
investigated	O
as	O
representative	O
of	O
normal	O
conditions	I:C0231162
.	O

In	O
addition	O
,	O
12	O
breast	O
tissue	I:C0444070
samples	I:C0444070
obtained	O
from	O
premenopausal	O
women	O
without	O
a	O
history	O
of	O
breast	O
cancer	I:C0006142
were	O
also	O
investigated	O
as	O
representative	O
of	O
normal	B:C0231162
conditions	I:C0231162
.	O

Peritumoral	B:C3897941
adipose	O
tissues	I:C0001527
expressed	O
CYP19A1	O
approximately	O
threefold	O
higher	O
than	O
tumor	O
itself	O
(	O
p	O
=	O
0.001	O
)	O
.	O

Peritumoral	O
adipose	B:C0001527
tissues	I:C0001527
expressed	O
CYP19A1	O
approximately	O
threefold	O
higher	O
than	O
tumor	O
itself	O
(	O
p	O
=	O
0.001	O
)	O
.	O

Peritumoral	O
adipose	O
tissues	I:C0001527
expressed	O
CYP19A1	B:C1366496
approximately	O
threefold	O
higher	O
than	O
tumor	O
itself	O
(	O
p	O
=	O
0.001	O
)	O
.	O

Peritumoral	O
adipose	O
tissues	I:C0001527
expressed	O
CYP19A1	O
approximately	O
threefold	O
higher	O
than	O
tumor	B:C0027651
itself	O
(	O
p	O
=	O
0.001	O
)	O
.	O

A	O
nonsignificant	O
trend	O
toward	O
low	O
expression	B:C0017262
of	O
CYP17A1	O
was	O
observed	O
in	O
peritumoral	O
compared	O
to	O
tumor	O
tissue	I:C0475358
(	O
p	O
=	O
0.687	O
)	O
.	O

A	O
nonsignificant	O
trend	O
toward	O
low	O
expression	O
of	O
CYP17A1	B:C1413858
was	O
observed	O
in	O
peritumoral	O
compared	O
to	O
tumor	O
tissue	I:C0475358
(	O
p	O
=	O
0.687	O
)	O
.	O

A	O
nonsignificant	O
trend	O
toward	O
low	O
expression	O
of	O
CYP17A1	O
was	O
observed	O
in	O
peritumoral	B:C3897941
compared	O
to	O
tumor	O
tissue	I:C0475358
(	O
p	O
=	O
0.687	O
)	O
.	O

A	O
nonsignificant	O
trend	O
toward	O
low	O
expression	O
of	O
CYP17A1	O
was	O
observed	O
in	O
peritumoral	O
compared	O
to	O
tumor	B:C0475358
tissue	I:C0475358
(	O
p	O
=	O
0.687	O
)	O
.	O

Clinicopathological	O
parameters	O
and	O
patient	O
characteristics	O
which	O
are	O
accepted	O
as	O
risk	B:C0035648
factors	I:C0035648
for	O
breast	O
cancer	I:C0006142
were	O
also	O
associated	O
with	O
individual	O
and	O
combined	O
expressions	O
of	O
CYP17A1	O
and	O
CYP19A1	O
.	O

Clinicopathological	O
parameters	O
and	O
patient	O
characteristics	O
which	O
are	O
accepted	O
as	O
risk	O
factors	I:C0035648
for	O
breast	B:C0006142
cancer	I:C0006142
were	O
also	O
associated	O
with	O
individual	O
and	O
combined	O
expressions	O
of	O
CYP17A1	O
and	O
CYP19A1	O
.	O

Clinicopathological	O
parameters	O
and	O
patient	O
characteristics	O
which	O
are	O
accepted	O
as	O
risk	O
factors	I:C0035648
for	O
breast	O
cancer	I:C0006142
were	O
also	O
associated	O
with	O
individual	O
and	O
combined	O
expressions	B:C0017262
of	O
CYP17A1	O
and	O
CYP19A1	O
.	O

Clinicopathological	O
parameters	O
and	O
patient	O
characteristics	O
which	O
are	O
accepted	O
as	O
risk	O
factors	I:C0035648
for	O
breast	O
cancer	I:C0006142
were	O
also	O
associated	O
with	O
individual	O
and	O
combined	O
expressions	O
of	O
CYP17A1	B:C1413858
and	O
CYP19A1	O
.	O

Clinicopathological	O
parameters	O
and	O
patient	O
characteristics	O
which	O
are	O
accepted	O
as	O
risk	O
factors	I:C0035648
for	O
breast	O
cancer	I:C0006142
were	O
also	O
associated	O
with	O
individual	O
and	O
combined	O
expressions	O
of	O
CYP17A1	O
and	O
CYP19A1	B:C1366496
.	O

This	O
study	O
offers	O
that	O
evaluation	B:C0220825
of	O
CYP17A1	O
and	O
CYP19A1	O
local	O
expression	O
levels	O
might	O
be	O
useful	O
for	O
deciding	O
on	O
personalized	O
treatment	O
approaches	O
and	O
more	O
accurate	O
diagnosis	O
,	O
when	O
evaluated	O
together	O
with	O
several	O
clinicopathological	O
and	O
disease	O
risk	O
factors	O
.	O

This	O
study	O
offers	O
that	O
evaluation	O
of	O
CYP17A1	B:C1413858
and	O
CYP19A1	O
local	O
expression	O
levels	O
might	O
be	O
useful	O
for	O
deciding	O
on	O
personalized	O
treatment	O
approaches	O
and	O
more	O
accurate	O
diagnosis	O
,	O
when	O
evaluated	O
together	O
with	O
several	O
clinicopathological	O
and	O
disease	O
risk	O
factors	O
.	O

This	O
study	O
offers	O
that	O
evaluation	O
of	O
CYP17A1	O
and	O
CYP19A1	B:C1366496
local	O
expression	O
levels	O
might	O
be	O
useful	O
for	O
deciding	O
on	O
personalized	O
treatment	O
approaches	O
and	O
more	O
accurate	O
diagnosis	O
,	O
when	O
evaluated	O
together	O
with	O
several	O
clinicopathological	O
and	O
disease	O
risk	O
factors	O
.	O

This	O
study	O
offers	O
that	O
evaluation	O
of	O
CYP17A1	O
and	O
CYP19A1	O
local	B:C0205276
expression	O
levels	O
might	O
be	O
useful	O
for	O
deciding	O
on	O
personalized	O
treatment	O
approaches	O
and	O
more	O
accurate	O
diagnosis	O
,	O
when	O
evaluated	O
together	O
with	O
several	O
clinicopathological	O
and	O
disease	O
risk	O
factors	O
.	O

This	O
study	O
offers	O
that	O
evaluation	O
of	O
CYP17A1	O
and	O
CYP19A1	O
local	O
expression	O
levels	O
might	O
be	O
useful	O
for	O
deciding	O
on	O
personalized	O
treatment	O
approaches	O
and	O
more	O
accurate	O
diagnosis	B:C0011900
,	O
when	O
evaluated	O
together	O
with	O
several	O
clinicopathological	O
and	O
disease	O
risk	O
factors	O
.	O

This	O
study	O
offers	O
that	O
evaluation	O
of	O
CYP17A1	O
and	O
CYP19A1	O
local	O
expression	O
levels	O
might	O
be	O
useful	O
for	O
deciding	O
on	O
personalized	O
treatment	O
approaches	O
and	O
more	O
accurate	O
diagnosis	O
,	O
when	O
evaluated	B:C0220825
together	O
with	O
several	O
clinicopathological	O
and	O
disease	O
risk	O
factors	O
.	O

Considering	O
the	O
key	O
role	O
of	O
these	O
CYPs	B:C0796517
in	O
estrogen	O
synthesis	I:C1157310
,	O
determining	O
their	O
expression	O
levels	O
may	O
be	O
useful	O
as	O
a	O
postdiagnostic	O
marker	I:C0005516
and	O
for	O
choosing	O
the	O
right	O
treatment	O
method	I:C0087111
in	O
addition	O
to	O
the	O
conventional	O
approach	O
.	O

Considering	O
the	O
key	O
role	O
of	O
these	O
CYPs	O
in	O
estrogen	B:C1157310
synthesis	I:C1157310
,	O
determining	O
their	O
expression	O
levels	O
may	O
be	O
useful	O
as	O
a	O
postdiagnostic	O
marker	I:C0005516
and	O
for	O
choosing	O
the	O
right	O
treatment	O
method	I:C0087111
in	O
addition	O
to	O
the	O
conventional	O
approach	O
.	O

Considering	O
the	O
key	O
role	O
of	O
these	O
CYPs	O
in	O
estrogen	O
synthesis	I:C1157310
,	O
determining	O
their	O
expression	O
levels	O
may	O
be	O
useful	O
as	O
a	O
postdiagnostic	B:C0005516
marker	I:C0005516
and	O
for	O
choosing	O
the	O
right	O
treatment	O
method	I:C0087111
in	O
addition	O
to	O
the	O
conventional	O
approach	O
.	O

Considering	O
the	O
key	O
role	O
of	O
these	O
CYPs	O
in	O
estrogen	O
synthesis	I:C1157310
,	O
determining	O
their	O
expression	O
levels	O
may	O
be	O
useful	O
as	O
a	O
postdiagnostic	O
marker	I:C0005516
and	O
for	O
choosing	O
the	O
right	O
treatment	B:C0087111
method	I:C0087111
in	O
addition	O
to	O
the	O
conventional	O
approach	O
.	O

